Diflu

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diflu

Understanding Diflu

Diflu is an antifungal medication specifically formulated to treat a variety of fungal and yeast infections. It belongs to a class of drugs known as triazole antifungals. Unlike topical treatments that are applied to the skin, this medication works systemically by circulating through the bloodstream to reach the site of the infection.

How It Works

The active mechanism of Diflu involves interfering with the ability of fungi to reproduce and maintain their cellular structure. It inhibits the synthesis of ergosterol, a vital component of the fungal cell membrane. When the cell membrane is compromised, the fungal cells cannot function properly, leading to their eventual death or the cessation of their growth. This process helps the body's natural immune system to clear the remaining infection more effectively.

Primary Uses

This medication is primarily utilized for the management of internal and external fungal conditions. It is frequently indicated for:

  • Vaginal yeast infections: Addressing overgrowth of Candida in the vaginal tract.
  • Oropharyngeal and esophageal candidiasis: Treating fungal infections that affect the mouth and throat.
  • Systemic fungal infections: Managing more widespread infections that may affect the lungs, urinary tract, or blood.
  • Cryptococcal meningitis: Supporting the treatment of specific fungal infections that affect the brain and spinal cord membranes.

Diflu is also used in certain clinical scenarios to prevent fungal infections in individuals with weakened immune systems who are more susceptible to opportunistic pathogens.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Diflu?

Possible Side Effects and Safety Information

Diflu (fluconazole) is generally well-tolerated, but like all medications, it is associated with a range of possible side effects and important safety considerations documented in regulatory labeling.

Adverse Reactions

The most commonly reported adverse reactions (very common to common) primarily affect the gastrointestinal and nervous systems and may include headache, nausea, abdominal pain, vomiting, and diarrhea.

Serious and Clinically Significant Risks

Regulatory warnings highlight the potential for rare but serious adverse events, which often occur in patients with serious underlying medical conditions:

  • Hepatotoxicity: Rare cases of serious liver damage, including hepatic failure and fatalities, have been reported. This risk is primarily noted in patients with severe underlying illnesses such as AIDS or malignancy.
  • Severe Cutaneous Reactions: Serious exfoliative skin disorders, including Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (TEN), may occur. The risk is elevated in patients with AIDS.
  • Cardiac Effects: The drug has been associated with QT interval prolongation and Torsades de pointes, particularly in patients with multiple risk factors like structural heart disease, electrolyte abnormalities (e.g., hypokalemia), or concurrent use of other QT-prolonging medications.
  • Anaphylaxis and other severe hypersensitivity reactions have been reported.

Safety Restrictions and Monitoring

  • Contraindications exist for co-administration with other drugs that prolong the QT interval and are metabolized by the CYP3A4 enzyme, such as pimozide, quinidine, and erythromycin.
  • Pregnancy: Use of high-dose Diflu (400–800 mg/day) during the first trimester has been associated with a rare, specific pattern of congenital malformations; use should be avoided except in life-threatening infections where benefits outweigh fetal risks.
  • Liver Function: Monitoring of liver enzyme function is necessary during therapy, and the drug should be permanently discontinued if signs or symptoms consistent with liver disease, or a rash attributed to Diflu, develop.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Diflu (Fluconazole) describes the necessary actions and documented manifestations in the event of an overdosage.

Feature Official Regulatory Statement
Documented Overdose Manifestations Cases of overdosage have been reported, with clinical manifestations involving Central Nervous System (CNS) effects. Specifically, hallucination and paranoid behavior have been reported concomitantly.
Antidote Information No specific antidote is available or documented in the official prescribing information.
Immediate Action Required Patients must get medical help or contact a Poison Control Center immediately in the event of an overdose.

The management of overdosage is symptomatic and supportive. Regulatory guidance outlines procedural measures for clearance due to the drug’s elimination profile. These measures may include gastric lavage if deemed necessary. Furthermore, haemodialysis is documented as an effective procedural option, with a three-hour session capable of decreasing Fluconazole plasma levels by approximately 50%. Forced volume diuresis is also noted as a method that would likely increase the rate of drug elimination.

Therapeutic Uses of Diflu

Diflu is an antifungal agent generally used across conditions presenting with systemic or localized discomfort caused by fungal activity. This medication plays a role in managing a spectrum of infections, providing supportive relief that helps ease the overall symptom burden. It is considered relevant in conditions presenting with systemic or localized discomfort, including serious, deep-seated infections and mucosal manifestations.

The medication is commonly used across conditions involving inflammatory or irritative processes, providing symptomatic relief that helps patients cope more steadily with symptom fluctuations. This includes managing symptoms related to physical discomfort such as pain, burning, and irritation in mucosal candidiasis, as well as addressing symptoms related to systemic imbalance in more severe disease. Furthermore, it is relevant when supportive symptom management is appropriate, as it is commonly used to help with reducing the risk of the onset of fungal manifestations in high-risk patients.

“Diflu is relevant when supportive symptom management is appropriate and contributes to improved comfort during periods of heightened fungal activity.”

It is also applied in addressing visible physical manifestations like scaling and redness in dermatological fungal conditions, and supports general well-being during symptomatic phases.


Quick Fact: Relief for Localized and Systemic Discomfort The medication is considered relevant for easing symptoms that interfere with daily functioning due to acute thrush, and for managing symptoms related to systemic imbalance in critical care settings.


Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Diflu?

Eligibility for Diflu (Fluconazole) is strictly defined by regulatory prescribing information, setting clear boundaries on who can and cannot use the medicine.


Absolute Restrictions (Contraindications)

The medicine is absolutely prohibited for individuals with known hypersensitivity (allergy) to Fluconazole, other azole antifungal agents, or any inactive ingredients in the specific product formulation. Additionally, Diflu must not be used concurrently with specific medications known to prolong the QT interval and metabolized by the CYP3A4 enzyme (e.g., astemizole, pimozide, halofantrine), as this combination is strictly contraindicated.


Age and Conditional Use

Population Group Eligibility Status (Regulatory Basis)
Adults Standard eligible population.
Pediatric Patients Use is established for many indications; however, efficacy for genital candidiasis is not established.
Pregnant/Lactating Women High-dose, prolonged use is contraindicated in pregnancy. Use in general is not recommended unless clearly necessary. Caution is advised during breastfeeding.
Renal Impairment Conditional use; the dosing schedule must be adjusted for patients with impaired kidney function.
Hepatic/Cardiac Conditions Use requires caution and close monitoring due to potential risks to liver function and for patients with cardiac risk factors (e.g., risk of QT prolongation).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Diflu (Fluconazole) has documented interaction patterns that primarily involve altering the plasma concentrations of co-administered medicinal products, which is strictly based on regulatory documentation. Fluconazole is a potent inhibitor of Cytochrome P450 isoenzymes CYP2C9 and CYP2C19, and a moderate inhibitor of CYP3A4.

Contraindicated Combinations

Co-administration is contraindicated with several drugs due to the potential for serious adverse cardiac events, specifically QTc prolongation risk. The prohibited agents include Cisapride, Astemizole, Pimozide, Quinidine, and Erythromycin. Co-administration with Terfenadine is also prohibited at multiple daily doses of 400 mg or higher.

Pharmacokinetic and Pharmacodynamic Effects

Interactions affect exposure to various drug classes. Fluconazole has been shown to significantly increase the AUC (exposure) of co-administered agents, including oral contraceptives, immunosuppressants (e.g., Cyclosporine, Tacrolimus), and certain anticonvulsants. Conversely, co-administration with Rifampin is documented to decrease the exposure of Fluconazole itself. The drug may be taken without regard to meals as food does not affect its absorption. Official labeling notes that the drug's pharmacokinetics are markedly affected by reduced renal function, which is an important consideration for its overall interaction profile.

Mechanism of Action

How Diflu Works: Mechanism of Action


Selective Inhibition of Fungal Enzyme Systems

Diflu primarily acts by selectively binding to and inhibiting lanosterol 14-alpha demethylase (CYP51), a crucial enzyme within the fungal cell's metabolic system. This highly targeted inhibition prevents a necessary conversion step, initiating the downstream cascade that restricts the pathogen's ability to maintain its structure and function.

Disruption of Fungal Cell Membrane Synthesis

The blocked conversion step prevents the formation of essential ergosterol and forces the incorporation of toxic 14-alpha-methyl sterols into the fungal cell membrane. This fundamental structural flaw compromises the membrane's integrity and permeability, resulting in a physiological state that inhibits the fungal organism's growth and replication (fungistasis).

Mechanistic Constraints and Resistance Patterns

The mechanism of action is constrained by biological counter-mechanisms, such as the overexpression of efflux pumps by the fungus, which actively expel the drug, or by mutation of the target enzyme. These adaptive fungal responses can reduce the concentration of the drug at the target site, limiting the extent of the biosynthesis blockade and diminishing the necessary molecular interaction at the enzyme target.

Dosage and Administration Information

How Diflu is Used: Official Administration Principles

Diflu (fluconazole) is administered via the Oral route (capsule, tablet, or suspension) or the Intravenous (IV) route (solution for infusion). This flexibility ensures treatment can continue regardless of a patient’s clinical status, as the drug exhibits similar absorption characteristics through either method.


Dosing and Frequency Patterns

The general use pattern for multiple-dose regimens begins with a loading dose on the first day of treatment. This initial dose is typically twice the subsequent daily dose and is administered to quickly achieve stable drug concentrations. Following this, the maintenance dose is administered once daily. For certain conditions like acute vaginal candidiasis, the drug is used as a single oral dose of 150 mg. For long-term suppressive therapy, such as preventing the relapse of cryptococcal meningitis, the maintenance regimen of 200 mg once daily may continue for an extended period.


Special Administration Conditions and Adjustments

Oral forms of Diflu may be taken with or without food. For the intravenous solution, administration must adhere to a controlled rate, not exceeding 10 mL per minute (approximately 200 mg/hour). Usage instructions require dose modification for specific populations: the dose must be reduced by 50% for adult patients receiving repeat doses who have significantly impaired renal function (Creatinine Clearance leq 50 mL/min). For pediatric use, dosing is based on body weight, and neonates have distinct dosing intervals ranging from every 48 to 72 hours, depending on age.

Recent Clinical Evidence

Evidence for Systemic Fungal Infections

The core research that regulators have relied on to evaluate Fluconazole (Diflu) for serious, deep-seated infections primarily consists of Randomized Controlled Trials (RCTs), supported by Meta-analyses. These studies focus on infections like systemic candidiasis and candidemia (fungal infection of the bloodstream). Specifically, studies explored short-term changes and outcomes related to patient survival over periods such as 14 or 30 days, alongside measurements of mycological eradication (fungal clearance). Findings from these studies describe patterns related to patient survival when the medicine was evaluated as a standard comparator in trials.

Evidence for Localized Mucosal Candidiasis

The use of this medicine for common conditions such as oral, esophageal, and vaginal thrush has been widely studied, with evidence derived from numerous short-term RCTs and Systematic Reviews. Researchers studied the rate of symptomatic relief (reduction in burning or pain), alongside the achievement of clinical and mycological cure. Findings describe patterns observed in these studies related to the resolution of visible manifestations and outcomes related to physical discomfort. Research provides insight into short-term changes in conditions characterized by fluctuating or episodic manifestations.

Evidence for Prophylaxis in High-Risk Patients

Research on the role of Fluconazole in preventing fungal infections in vulnerable patients was evaluated using Placebo-controlled RCTs and associated Meta-analyses. The primary outcomes monitored were the incidence rate of confirmed fungal infections during the prophylactic period and overall patient survival. Research highlights changes measured during the study period, with data showing patterns related to the measured rate of documented fungal infection in the observed populations. However, the evidence is limited and narrowly focused on specific clinical settings (e.g., transplant types).

Long-Term Evidence and Follow-Up in Maintenance Therapy

For maintenance therapy (e.g., Cryptococcal Meningitis), the medicine was evaluated in Comparative RCTs and Long-term Observational Studies. The main outcomes studied included the frequency of disease relapse or recurrence and long-term overall survival of patients. Studies report how symptoms evolved in the observed populations over extended durations. The research base for maintenance therapy was primarily conducted on specific populations, such as adults with HIV, meaning that data for other groups of immunocompromised patients are still emerging.

Frequently Asked Questions (FAQ)

Common questions about Diflu (FAQ)


Q: What is Diflu used for, besides the main thing?

A: Official documents indicate that Diflu (fluconazole) is approved to treat various infections beyond its primary use. This includes specific types of candidiasis affecting the vagina, esophagus, and mouth, as well as systemic Candida infections and cryptococcal meningitis. It is also utilized for the prevention of fungal infections in specific high-risk patient populations with weakened immune systems.


Q: Does Diflu need to be taken at the same time every day?

A: The official administration instructions describe the maintenance regimen as being administered once daily. The guidance for a missed dose refers to resuming the regular dosing schedule. This regulatory phrasing points to the general importance of maintaining consistency with the daily administration schedule.


Q: What happens if I miss a time I was supposed to take Diflu?

A: According to the Patient Information Leaflet, if a dose is missed, regulatory instructions describe taking it as soon as possible. However, if it is almost time for the next scheduled dose, the missed dose should be skipped entirely. The guidance is to then return to the regular schedule and avoid taking double doses to compensate for the missed dose.


Q: Is it normal to feel [minor, vague symptom like fatigue or dry mouth] when starting Diflu?

A: The most commonly reported side effects, such as headache or nausea, are generally described as mild to moderate and may resolve within a couple of weeks. Less frequently reported effects during post-marketing experience include symptoms such as fatigue and dry mouth. These effects are generally noted in the context of the drug's post-marketing safety data.


Q: Do the side effects of Diflu usually go away after a few weeks?

A: Studies and official information indicate that the common side effects experienced by patients, provided they are mild in nature, may resolve within a period of a few days or up to a couple of weeks. The persistence or severity of side effects is an element to be discussed with a healthcare professional.


Q: Is Diflu safe to use long-term?

A: The medicine is sometimes prescribed for long-term use, known as suppressive therapy, for certain conditions. When the drug is used for an extended period, rare long-term adverse events have been reported. These primarily concern the potential for serious effects on the liver and heart rhythm.


Q: Are there any foods or drinks that should be avoided when using Diflu?

A: The drug's oral forms may be taken with or without food, as food does not affect its absorption characteristics. However, regulatory documents describe an interaction with caffeine. This interaction may slow the body's clearance of caffeine, potentially increasing the risk of experiencing caffeine-related side effects.


Q: Is it okay to drink coffee while taking Diflu?

A: Official prescribing information indicates that fluconazole can slow down the speed at which the body processes caffeine. This pharmacological effect means that a patient may experience increased caffeine-related side effects. The information does not advise a prohibition but describes the mechanism of the interaction.


Q: What does 'contraindicated' mean in relation to Diflu?

A: The term 'contraindicated' is used in regulatory documents to describe an absolute restriction on the use of the medicine. It signifies that the drug's use is not permitted in patients with specific conditions, such as a known allergy to the drug, or when taken with certain concurrent medications.


Q: Is Diflu a controlled substance?

A: According to official regulatory labeling, fluconazole is not classified as a controlled substance. This designation relates to the drug's potential for abuse or dependence, which is not noted in its profile.


Q: How long does Diflu stay in your system after you stop taking it?

A: Regulatory pharmacokinetic studies describe the elimination of the drug from the body. Following the last dose, it typically takes about 6 days for fluconazole to be completely eliminated from the body. The effects of the medication are generally considered to end soon after the final dose.


Q: Does taking Diflu affect the results of common blood tests?

A: Regulatory documents mention the potential need for monitoring liver enzyme function in connection with the drug’s safety profile. Additionally, monitoring of lab tests like creatinine kinase may be necessary when the drug is co-administered with certain other medications.


Q: Is Diflu available as a generic medicine?

A: Yes, the active ingredient, fluconazole, is available in a generic form. The generic product has been approved by the FDA and is described as therapeutically equivalent to the original brand name product.


Q: What are the different strengths that Diflu comes in?

A: The drug is supplied in different strengths to accommodate various dosage needs. The oral capsules and tablets are officially available in 50 mg, 100 mg, 150 mg, and 200 mg strengths. It is also formulated as a solution for oral suspension and intravenous infusion.


Q: What does the patient information leaflet say about stopping Diflu?

A: The Patient Information Leaflet communicates the importance of continuing the full course of treatment. Regulatory instructions state that patients should continue using the medicine for the full prescribed treatment time to ensure the infection is cleared. The guidance is not to discontinue the medication based solely on symptoms improving earlier.


Q: What kind of interactions does Diflu have with herbal supplements?

A: While specific herbal supplements may not be listed, official patient counseling information includes the statement that a healthcare professional should be informed of all co-administered products. This is necessary because herbal supplements and other over-the-counter products may have undocumented interactions with the drug.


Q: How does Diflu affect sleep?

A: Central nervous system effects have been reported during post-marketing experience with the drug. These reports include instances of both insomnia (difficulty sleeping) and somnolence (drowsiness). These effects are generally reviewed as part of the overall adverse reaction profile.


Q: Why is it important to know about the drug's interactions?

A: Knowledge of drug interactions is critical because co-administration with certain agents is strictly contraindicated. This restriction is in place due to the potential for serious adverse events, such as a severe cardiac rhythm disturbance known as QTc prolongation.


Q: What are the long-term research findings related to Diflu's safety?

A: Long-term studies, such as observational studies, have been conducted for maintenance therapy, primarily focusing on disease recurrence and survival. Rare, serious side effects reported with extended use primarily concern potential issues with the liver and the heart rhythm.


Q: Do studies suggest Diflu affects mood?

A: Post-marketing experience data includes reports of mood changes and mental depression. These effects have been observed, sometimes in association with the rare risk of developing adrenal gland problems.


Q: Is Diflu safe for older adults (seniors)?

A: Studies have not shown specific problems that limit the usefulness of fluconazole in the elderly population. However, official information notes that older patients are more likely to have age-related kidney problems. This may be a factor when determining a dose adjustment for patients receiving repeat doses.


Q: What is the half-life of Diflu?

A: The term half-life describes the time it takes for half of the drug to be eliminated from the body. Pharmacokinetic studies show that the average plasma elimination half-life of fluconazole is approximately 30 hours.


Q: Is the effectiveness of Diflu affected by body weight?

A: Regulatory dosing guidelines indicate that the administration of the drug for pediatric patients is determined based on body weight. This approach helps ensure that appropriate plasma concentrations are achieved in children.


Q: What does the term 'pharmacodynamics' mean for Diflu?

A: Pharmacodynamics is the description of the effects of the drug on the body. For fluconazole, this involves the inhibition of the fungal enzyme lanosterol 14-alpha demethylase. This action prevents the formation of essential cell membrane components in the fungus.


Q: Are there different brand names for the same medicine as Diflu?

A: The active ingredient is known by the generic name fluconazole. The drug is commonly marketed under the original brand name Diflucan. Generic availability means the same active ingredient is sold under multiple names globally.


Q: Is it possible for Diflu to stop working over time?

A: Regulatory information on the drug's mechanism of action includes a section on resistance. This indicates that the drug's effectiveness may diminish over time due to adaptive resistance mechanisms in the fungus, such as the overexpression of efflux pumps.


Q: What are the warnings about driving or operating machinery while on Diflu?

A: Since the drug has been associated with central nervous system effects such as dizziness and somnolence (drowsiness), regulatory guidance includes a recommendation for caution. This is a general precaution to be considered when driving or operating machinery.


Q: Does Diflu affect fertility in men or women?

A: Human studies have not been performed to determine if fluconazole affects fertility in either men or women. This indicates that regulatory data does not provide a definitive statement on the drug's impact on reproductive capability.

How should Diflu be stored and disposed of?

Storage and Disposal Requirements for Diflucan (Fluconazole)

The storage of Diflucan must adhere strictly to official regulatory conditions and varies by formulation.


Storage Conditions

Formulation Temperature Requirement Stability Constraint
Capsules/Dry Powder Store at or below 30°C Must be protected from freezing
Reconstituted Suspension Store between 5°C and 30°C Discard after 14 days
IV Infusion Store according to label Must be protected from freezing

Handling and Disposal

All forms of this medicine must be kept out of the sight and reach of children, as required by regulatory labeling. Any unused or expired product must be disposed of according to local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diflu found in:

A-Z Index: